Clinical trial
MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal…
NCT00326456 · National Cancer Institute, Naples, Other · Unknown status
Key facts
| NCT number | NCT00326456 |
|---|---|
| Title | MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer |
| Official title | Phase III Randomized Multicentre Trial of Carboplatin + Liposomal Doxorubicin vs Carboplatin + Paclitaxel in Patients With Ovarian Cancer |
| Lead sponsor | National Cancer Institute, Naples, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | liposomal doxorubicin, carboplatin, paclitaxel |
| Enrollment | 820 |
| Start date | Jan 1, 2003 |
| Primary completion | Dec 1, 2023 |
| Completion | Dec 1, 2023 |
| First posted | May 16, 2006 |
| Last update posted | Mar 27, 2023 |
| Countries | Italy, Portugal, Turkey (Türkiye) |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: